Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure.
about
Therapeutic cloning: promises and issuesBlocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.Cyclosporin A induces apoptosis in H9c2 cardiomyoblast cells through calcium-sensing receptor-mediated activation of the ERK MAPK and p38 MAPK pathwaysHexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS productionTargeting mitochondrial dysfunction in the treatment of heart failure.Silent disease progression in clinically stable heart failure.Clinically-relevant consecutive treatment with isoproterenol and adenosine protects the failing heart against ischaemia and reperfusionGinsenoside rb1 protects neonatal rat cardiomyocytes from hypoxia/ischemia induced apoptosis and inhibits activation of the mitochondrial apoptotic pathwayCardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.The mitochondria-mediate apoptosis of Lepidopteran cells induced by azadirachtin.Docosahexaenoic acid supplementation alters key properties of cardiac mitochondria and modestly attenuates development of left ventricular dysfunction in pressure overload-induced heart failureMitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failureSirtuin-4 modulates sensitivity to induction of the mitochondrial permeability transition pore.Restoration of lysosomal pH in RPE cells from cultured human and ABCA4(-/-) mice: pharmacologic approaches and functional recovery.Marine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival.Cyclosporine A Suppressed Glucose Oxidase Induced P53 Mitochondrial Translocation and Hepatic Cell Apoptosis through Blocking Mitochondrial Permeability Transition.Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.Chronic therapy with a partial adenosine A1-receptor agonist improves left ventricular function and remodeling in dogs with advanced heart failure.Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.Cyclosporin A in left ventricular remodeling after myocardial infarction.Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.Expert consensus document: Mitochondrial function as a therapeutic target in heart failureTargeting the mitochondrial permeability transition: cardiac ischemia-reperfusion versus carcinogenesis.Cardiac metabolism in hypertrophy and heart failure: implications for therapy.Partial adenosine A1 receptor agonism: a potential new therapeutic strategy for heart failure.Mitochondrial PKC-ε deficiency promotes I/R-mediated myocardial injury via GSK3β-dependent mitochondrial permeability transition pore opening.The compound BTB06584 is an IF1 -dependent selective inhibitor of the mitochondrial F1 Fo-ATPase.Ginsenoside Rb1 protects cardiomyocytes against CoCl2-induced apoptosis in neonatal rats by inhibiting mitochondria permeability transition pore opening.Regulation of mitochondrial permeability transition pore by PINK1.Infarct size reduction by cyclosporine A at reperfusion involves inhibition of the mitochondrial permeability transition pore but does not improve mitochondrial respiration.Mitochondria: from basic biology to cardiovascular disease.Cyclosporine A cardioprotection: mechanisms and potential for clinical application.Mitochondrial Mechanosensor Microdomains in Cardiovascular Disorders.Over-expression of mitochondrial creatine kinase in the murine heart improves functional recovery and protects against injury following ischaemia-reperfusion.Effects of Artemetin on Nitric Oxide Release and Protection against Peroxidative Injuries in Porcine Coronary Artery Endothelial Cells.
P2860
Q24645082-C166A999-67D9-4C67-A477-F160F99239DEQ27330087-39F97E9C-FD5F-47CA-8A3C-BBB5C77223E1Q28584308-01BC119E-73AE-4470-A989-CE77B0F7DB4EQ28592204-90E0103D-B668-41EA-89C7-B46DFAEFBD12Q30243930-8A026F88-E529-48D4-8130-7AA99A45B116Q33578212-BC02022C-9C42-4534-B36E-A89D005E0064Q33712409-94B785B9-F616-4C9E-9350-E6E610FA7082Q33996737-F53DE3EA-9498-45F4-868E-5921BF5134CFQ34049082-80ECDD92-9B7A-4466-8982-7B5FBA8E3F88Q34629662-94D2FFA5-51C2-47C4-8E07-EC2749D58CC6Q35191017-B341C91E-BFEC-455B-9B61-F30883269EE4Q35953116-7817935E-82CF-4059-896A-CB0B501C82ABQ36401146-9B67A117-DB2C-4BDB-837C-6858602AEB90Q36518020-491DC3A9-9404-43EB-9FF3-6EDB910E4E18Q36528123-9865B425-62B1-4C9B-83BA-207B4C7D5085Q36534051-0F179BFE-6508-4AA9-B334-13E090B59A05Q36550830-2D8D5F3F-F309-4AAA-BC77-6D9C07CE43E9Q37214190-FCE12703-7F65-4060-AC41-96103B089BFBQ37508249-F8962AC3-CA6F-4C80-A469-A25FF9AF6979Q37575962-9162FCEA-E26C-487C-8B9C-5C70A15AF385Q37601041-156A9E63-EBA9-4F86-8433-8BD910A63F61Q37699474-BFE36855-BE5E-4963-9D8D-17D40C791F0DQ37862534-579B00B8-DD9F-4165-A748-F710954EBDD8Q38057699-701CC350-BD79-474D-A670-62B300191A6FQ38678461-A0E02AF0-F9BC-4763-B11D-81E12FA85E5EQ38925635-4DA377E9-D3F3-4244-8882-9A2E88BFB25EQ39014411-1DA846AC-4A13-4D3B-A25E-B9C44975D7C4Q39022253-92F5ADD3-3D84-4DB6-9C95-FB1012626D9DQ41786008-339C3BBA-8F95-46D6-AC02-3A9FB014C4F5Q41892475-7C00C0E9-6775-4E78-B7D6-96C8BA101B42Q41980324-EF6070C4-076C-412E-B100-6C87F06C9D53Q43086748-833045C2-C33F-4885-B70C-D6701AEB975CQ46359838-D87BD534-69AF-4305-8823-AAAD3EB76595Q52728556-4FA16476-0A2E-4F17-9043-A04F51376653Q54268714-F3EBD96B-56E7-40D6-A393-DA90BA9A340C
P2860
Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cyclosporine A attenuates mito ...... from dogs with heart failure.
@en
Cyclosporine A attenuates mito ...... from dogs with heart failure.
@nl
type
label
Cyclosporine A attenuates mito ...... from dogs with heart failure.
@en
Cyclosporine A attenuates mito ...... from dogs with heart failure.
@nl
prefLabel
Cyclosporine A attenuates mito ...... from dogs with heart failure.
@en
Cyclosporine A attenuates mito ...... from dogs with heart failure.
@nl
P2093
P2860
P1476
Cyclosporine A attenuates mito ...... from dogs with heart failure.
@en
P2093
Anastassia Todor
Hani N Sabbah
Makoto Imai
Sanjaya Khanal
Victor G Sharov
P2860
P304
P356
10.1016/J.YJMCC.2006.09.013
P577
2006-10-27T00:00:00Z